Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Huanghai Pharmaceutical To Set Up RMB 100 Million Production Base

This article was originally published in PharmAsia News

Executive Summary

Qingdao Huanghai Pharmaceutical, China's only pharmaceutical company to have more than five products in sustained- and controlled-release technology, has begun construction of its phase two pharmaceutical high-tech industrial park program. At a total investment of more than RMB 100 million, the project is built according to GMP requirements with 8,000 square meters of factory floor space and 4,000 square meters of auxiliary warehouse. Scheduled for operation this October, the plant can produce 2.5 billion sustained- and controlled-release tablets. According to Huanghai officials, R&D and innovation will represent the fundamental tenet of the base. The firm will continue to improve its sustained-release technology platform in the next two years and develop pulsed, targeted-drug administration. (Click here for more - Chinese language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel